Correlation Between Third Point and Biotech Growth

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Third Point and Biotech Growth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Third Point and Biotech Growth into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Third Point Investors and The Biotech Growth, you can compare the effects of market volatilities on Third Point and Biotech Growth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Third Point with a short position of Biotech Growth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Third Point and Biotech Growth.

Diversification Opportunities for Third Point and Biotech Growth

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between Third and Biotech is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Third Point Investors and The Biotech Growth in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotech Growth and Third Point is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Third Point Investors are associated (or correlated) with Biotech Growth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotech Growth has no effect on the direction of Third Point i.e., Third Point and Biotech Growth go up and down completely randomly.

Pair Corralation between Third Point and Biotech Growth

Assuming the 90 days trading horizon Third Point Investors is expected to generate 0.71 times more return on investment than Biotech Growth. However, Third Point Investors is 1.41 times less risky than Biotech Growth. It trades about 0.05 of its potential returns per unit of risk. The Biotech Growth is currently generating about 0.01 per unit of risk. If you would invest  147,500  in Third Point Investors on April 20, 2025 and sell it today you would earn a total of  37,750  from holding Third Point Investors or generate 25.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Third Point Investors  vs.  The Biotech Growth

 Performance 
       Timeline  
Third Point Investors 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Third Point Investors are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Third Point is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Biotech Growth 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in The Biotech Growth are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Biotech Growth unveiled solid returns over the last few months and may actually be approaching a breakup point.

Third Point and Biotech Growth Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Third Point and Biotech Growth

The main advantage of trading using opposite Third Point and Biotech Growth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Third Point position performs unexpectedly, Biotech Growth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotech Growth will offset losses from the drop in Biotech Growth's long position.
The idea behind Third Point Investors and The Biotech Growth pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device